Drug Profile
Research programme: Pim kinase inhibitors - Jasco Pharmaceuticals
Alternative Names: JP 11646; JP_11646; Pim inhibitorsLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Jasco Pharmaceuticals
- Developer Jasco Pharmaceuticals; Roswell Park Cancer Institute
- Class Small molecules
- Mechanism of Action Proto oncogene proteins c pim 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in USA
- 14 Apr 2016 Drug interactions data from a preclinical study in Acute myeloid leukaemia presented at the 107th Annual Meeting of the American Association for Cancer Research (AACR-2016)
- 31 May 2013 Preclinical development is ongoing in USA